Test Price
2,800 AED✅ Home Collection Available
ABCC6 Gene Sequencing for Generalized Arterial Calcification Type 2 (Infantile) – Genetic Test in UAE
Executive Summary & Core Metrics
Comprehensive ABCC6 gene sequencing via Next-Generation Sequencing (NGS) with diagnostic sensitivity of 99.9%. Premium home collection service available daily 8 AM – 11 PM with ISO-certified cold-chain transport. DHA-licensed genetic counselling provided post-report. Insurance direct billing verification via WhatsApp +971 54 548 8731.
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139)
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM)
Clinical Guidance
Telephonic Post-Test Clinical Interpretation by DHA-Licensed Consultant Medical Geneticist
Insurance
Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The ABCC6 Gene Arterial Calcification Type 2 (Generalized, Infantile) Genetic Test is a definitive molecular diagnostic that screens the entire coding region of the ABCC6 gene for pathogenic variants, the primary cause of Generalized Arterial Calcification of Infancy (GACI) type 2 — a life-threatening autosomal recessive disorder characterized by extensive calcification of the internal elastic lamina of medium and large arteries.
| Feature | Our Test (NGS Sequencing) | Closest Alternative (Targeted Panel) |
|---|---|---|
| Precision | Full gene sequencing with copy number variant detection | Limited to predefined hot-spot mutations |
| Methodology | Next-Generation Sequencing (NGS) with Sanger confirmation | PCR-based fragment analysis or Sanger sequencing of select exons |
| Turnaround Time | 3–4 Weeks (ISO cold-chain preserved) | 4–6 Weeks |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I emphasize that this NGS test provides a molecular confirmation crucial for differential diagnosis of GACI, but results must be interpreted alongside clinical presentation, echocardiographic findings, and biochemical markers. False reassurance from a negative result is possible if the variant is deep intronic or a novel missense; thus, lifelong multidisciplinary follow-up remains essential.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory
⚠️ Medication Warning
Do not discontinue prescribed medication (e.g., bisphosphonates, etidronate, or antihypertensives) without consulting your treating physician. Genetic results guide long-term management but do not replace acute care interventions.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active febrile illness, recent blood transfusion (<2 weeks), or anticoagulation that cannot be safely paused per physician.
- Immediate ER Visit if: New onset of respiratory distress, cyanosis, sudden hypertension crisis, or seizure within 48 hours of blood draw.
- Post-test Safety: Minor bruising at venipuncture site is common; however, signs of limb ischemia or expanding hematoma demand urgent care.
Patient FAQ & Clinical Guidance
1. What is the ABCC6 gene test, and why is it ordered for my infant?
This test reads the entire ABCC6 gene to identify disease-causing mutations responsible for severe arterial calcification in newborns, enabling targeted therapy and family planning.
2. How is the sample collected, and does insurance cover it in the UAE?
A certified mobile phlebotomist collects a blood sample at your home between 8 AM and 11 PM, and we verify direct billing with your insurer via WhatsApp at +971 54 548 8731.
3. What happens after I receive a positive mutation result?
You will receive immediate telephonic genetic counselling and a personalized clinical correlation report, followed by a multidisciplinary referral to a paediatric cardiologist and metabolic specialist at a DHA-licensed facility.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Protection
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All patient data collected, processed, and stored in compliance with PDPL requirements for consent, purpose limitation, and data security.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: ICT systems and telephonic consultations adhere to the statutory standards for electronic health data handling and confidentiality.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Clinical procedures, patient consent, and safety protocols follow the established medical liability framework.
Clinical & Logistical Metadata
| Test Name | ABCC6 Gene Sequencing – Generalized Arterial Calcification Type 2 (Infantile) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | E83.59 |
| LOINC Code | 21615-9 (ABCC6 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians